Ziyad Al-Ali

Ziyad Al-Ali is the director of the Center for Clinical Epidemiology at the St. Louis Health Care System, recognized for his research on the effects of GLP-1 receptor agonists on addiction. His recent study analyzed data from over 606,000 veterans with Type 2 diabetes, revealing that patients using weight loss injections experienced significantly lower incidences of substance abuse compared to those on other diabetes medications.